Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
Somatic cell nuclear transfer allows trans-acting factors present in the mammalian oocyte to reprogram somatic cell nuclei to an undifferentiated state. We show that four factors ( OCT4, SOX2, NANOG , and LIN28 ) are sufficient to reprogram human somatic cells to pluripotent stem cells that exhibit the essential characteristics of embryonic stem (ES) cells. These induced pluripotent human stem cells have normal karyotypes, express telomerase activity, express cell surface markers and genes that characterize human ES cells, and maintain the developmental potential to differentiate into advanced derivatives of all three primary germ layers. Such induced pluripotent human cell lines should be useful in the production of new disease models and in drug development, as well as for applications in transplantation medicine, once technical limitations (for example, mutation through viral integration) are eliminated.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Retro/lentiviruses have enabled genetic approaches in cultured primary cells to ectopically express genes of interest (1–6).”
From Establishment of single-cell screening system for the rapid identification of transcriptional modulators involved in direct cell reprogramming (2012) · cites this paper as [3]
In the citing paper
“Viral screens using focused overexpression libraries can identify putative reprogramming factors, for example, by identifying a defined set of transcription factors that are selectively required to induce pluripotent stem cells (2–4,7) or trans-differentiate from mature somatic cell into another mature somatic cell (1,8–11).”
From Establishment of single-cell screening system for the rapid identification of transcriptional modulators involved in direct cell reprogramming (2012) · cites this paper as [3]
In the citing paper
“Despite the power of viral technologies, pooled screens for cell reprogramming have generally adopted a one-by-one elimination approach or testing for exhaustive combinations and interrogating phenotypes in cell culture from transgenic mice (1,3,10) and/or aberrantly cloned cell lines (12).”
From Establishment of single-cell screening system for the rapid identification of transcriptional modulators involved in direct cell reprogramming (2012) · cites this paper as [3]
In the citing paper
“Successful transformation of human somatic cells into iPSCs was first carried out in 2007 using a lentiviral system [95].”
From Non-Integrating Lentiviral Vectors in Clinical Applications: A Glance Through (2022) · cites this paper as [95]
In the citing paper
“It has been shown that NANOG and LIN28 in combination with SOX2 and OCT4 can reprogram human somatic cells into iPS cells 30 by increasing reprogramming efficiency by 76-fold 60 .”
From Mechanisms, pathways and strategies for rejuvenation through epigenetic reprogramming (2023) · cites this paper as [30]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
Embryonic Stem Cell Lines Derived from Human Blastocysts
Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., Waknitz, M. A., Swiergiel, J. J., Marshall, V. S., & Jones, J. M. (1998) · Science · doi:10.1126/science.282.5391.1145 · Cited by 15,926
Self-citationThe ENCODE Project Consortium (2007) · Nature · doi:10.1038/nature05874 · Cited by 5,223
Viable offspring derived from fetal and adult mammalian cells
Wilmut, I., Schnieke, A. E., McWhir, J., Kind, A. J., & Campbell, K. H. S. (1997) · Nature · doi:10.1038/385810a0 · Cited by 4,969
Generation of germline-competent induced pluripotent stem cells
Okita, K., Ichisaka, T., & Yamanaka, S. (2007) · Nature · doi:10.1038/nature05934 · Cited by 4,299
In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state
Wernig, M., Meissner, A., Foreman, R., Brambrink, T., Ku, M., Hochedlinger, K., Bernstein, B. E., & Jaenisch, R. (2007) · Nature · doi:10.1038/nature05944 · Cited by 2,676
Maherali, N., Sridharan, R., Xie, W., Utikal, J., Eminli, S., Arnold, K., Stadtfeld, M., Yachechko, R., Tchieu, J., Jaenisch, R., et al. (2007) · Cell stem cell · doi:10.1016/j.stem.2007.05.014 · Cited by 1,725
Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells
Meissner, A., Wernig, M., & Jaenisch, R. (2007) · Nature Biotechnology · doi:10.1038/nbt1335 · Cited by 763
Homologous recombination in human embryonic stem cells
Zwaka, T. P., & Thomson, J. A. (2003) · Nature Biotechnology · doi:10.1038/nbt788 · Cited by 666
Self-citationVodyanik, M. A., Bork, J. A., Thomson, J. A., & Slukvin, I. I. (2005) · Blood · doi:10.1182/blood-2004-04-1649 · Cited by 619
Self-citation
Cited by
Items 601–700 of 1,133
p53 Regulates Cell Cycle and MicroRNAs to Promote Differentiation of Human Embryonic Stem Cells
Jain, A. K., Allton, K., Iacovino, M., Mahen, E., Milczarek, R. J., Zwaka, T. P., Kyba, M., & Barton, M. C. (2012) · PLoS Biology · doi:10.1371/journal.pbio.1001268 · Cited by 227
“functionally and phenotypically similar to ESCs [8,9].”
Gu, Q., Tomaskovic‐Crook, E., Wallace, G. G., & Crook, J. M. (2017) · Advanced Healthcare Materials · doi:10.1002/adhm.201700175 · Cited by 228
Cell Sources for Cultivated Meat: Applications and Considerations throughout the Production Workflow
Reiss, J., Robertson, S., & Suzuki, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147513 · Cited by 219
“iPSCs are generated by cell reprogramming of somatic cells via the induction of genes associated with pluripotency [55,56].”
BackgroundHuman iPS cell–derived alveolar epithelium repopulates lung extracellular matrix
Ghaedi, M., Calle, E. A., Mendez, J. J., Gard, A. L., Balestrini, J., Booth, A., Bove, P. F., Gui, L., White, E. S., & Niklason, L. E. (2013) · Journal of Clinical Investigation · doi:10.1172/jci68793 · Cited by 230
“Given that iPSCs can be derived from the patient to be treated, they could provide a cell source that is genetically identical to the patient, allowing tissue generated from these cells to avoid immune rejection (9, 12).”
Controlling Self-Renewal and Differentiation of Stem Cells via Mechanical Cues
Nava, M. M., Raimondi, M. T., & Pietrabissa, R. (2012) · Journal of Biomedicine and Biotechnology · doi:10.1155/2012/797410 · Cited by 225
“To this purpose, we introduce the concept of “force isotropy” relevant to cytoskeletal forces and relevant to extracellular loads acting on cells.”
BackgroundStem Cell Imaging: From Bench to Bedside
Nguyen, P. K., Riegler, J., & Wu, J. C. (2014) · Cell Stem Cell · doi:10.1016/j.stem.2014.03.009 · Cited by 234
“Although the discovery of iPSCs offered a potential solution to immune rejection (Takahashi et al., 2007; Yu et al., 2007), Zhao et al. reported that murine iPSCs were also rejected after transplantation into syngeneic recipients (Zhao et al., 2011).”
Induced Pluripotent Stem Cells: Problems and Advantages when Applying them in Regenerative Medicine
Medvedev, S. P., Shevchenko, A. I., & Zakian, S. M. (2010) · Acta Naturae · doi:10.32607/20758251-2010-2-2-18-27 · Cited by 232
Vatine, G. D., Al-Ahmad, A., Barriga, B. K., Svendsen, S., Salim, A., Garcia, L., Garcia, V. J., Ho, R., Yucer, N., Qian, T., et al. (2017) · Cell Stem Cell · doi:10.1016/j.stem.2017.04.002 · Cited by 233
“Technologies to reprogram adult cells back to a pluripotent state, termed induced pluripotent stem cells (iPSCs) (Takahashi and Yamanaka, 2006; Yu et al., 2007), provide an unprecedented platform for studying human genetic disorders (Ebert et al., 2009; Mattis et al., 2015).”
BackgroundZhao, W., Ji, X., Zhang, F., Li, L., & Ma, L. (2012) · Molecules · doi:10.3390/molecules17066196 · Cited by 224
“induction of iPS cells by different groups [96,105].”
BackgroundSteinert, A. F., Rackwitz, L., Gilbert, F., Nöth, U., & Tuan, R. S. (2012) · Stem Cells Translational Medicine · doi:10.5966/sctm.2011-0036 · Cited by 229
Embryonic stem cell and induced pluripotent stem cell: an epigenetic perspective
Liang, G., & Zhang, Y. (2013) · Cell Research · doi:10.1038/cr.2012.175 · Cited by 224
Zhao, T., Zhang, Z.-N., Westenskow, P. D., Todorova, D., Hu, Z., Lin, T., Rong, Z., Kim, J., He, J., Wang, M., et al. (2015) · Cell Stem Cell · doi:10.1016/j.stem.2015.07.021 · Cited by 226
“…could be mitigated by the development of patient-specific hiPSCs without the concern of immune rejection (Park et al., 2008; Takahashi et al., 2007; Yu et al., 2007), recent studies have shown that certain cell types derived from mouse iPSCs such as cardiomyocytes are immunogenic in syngeneic…”
BackgroundLIN-28 and the poly(U) polymerase PUP-2 regulate let-7 microRNA processing in Caenorhabditis elegans
Lehrbach, N. J., Armisen, J., Lightfoot, H. L., Murfitt, K. J., Bugaut, A., Balasubramanian, S., & Miska, E. A. (2009) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1675 · Cited by 229
“Lin28 is a conserved RNA-binding protein that, in mammals, controls stem cell lineages and inhibits let-7 miRNA processing in vitro”
BackgroundActions of human telomerase beyond telomeres
Cong, Y., & Shay, J. W. (2008) · Cell Research · doi:10.1038/cr.2008.74 · Cited by 229
Koyanagi-Aoi, M., Ohnuki, M., Takahashi, K., Okita, K., Noma, H., Sawamura, Y., Teramoto, I., Narita, M., Sato, Y., Ichisaka, T., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1319061110 · Cited by 227
“Two types of human pluripotent stem cells have been generated: human embryonic stem cells (hESCs) derived from blastocysts (1) and induced pluripotent stem cells (hiPSCs), which are generated from somatic cells by factor-mediated reprogramming (2, 3).”
BackgroundQiang, L., Fujita, R., Yamashita, T., Angulo, S., Rhinn, H., Rhee, D., Doege, C., Chau, L., Aubry, L., Vanti, W. B., et al. (2011) · Cell · doi:10.1016/j.cell.2011.07.007 · Cited by 231
“into Functional Neurons”
RetractedCell sources for in vitro human liver cell culture models
Zeilinger, K., Freyer, N., Damm, G., Seehofer, D., & Knöspel, F. (2016) · Experimental Biology and Medicine · doi:10.1177/1535370216657448 · Cited by 230
In vitro pharmacologic testing using human induced pluripotent stem cell-derived cardiomyocytes
Tanaka, T., Tohyama, S., Murata, M., Nomura, F., Kaneko, T., Chen, H., Hattori, F., Egashira, T., Seki, T., Ohno, Y., et al. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.05.073 · Cited by 226
Modeling Familial Cancer with Induced Pluripotent Stem Cells
Lee, D.-F., Su, J., Kim, H. S., Chang, B., Papatsenko, D., Zhao, R., Yuan, Y., Gingold, J., Xia, W., Darr, H., et al. (2015) · Cell · doi:10.1016/j.cell.2015.02.045 · Cited by 224
Concise Review: Isoforms of OCT4 Contribute to the Confusing Diversity in Stem Cell Biology
Wang, X., & Dai, J. (2010) · Stem Cells · doi:10.1002/stem.419 · Cited by 223
Tissue engineering of human bladder
Atala, A. (2011) · British Medical Bulletin · doi:10.1093/bmb/ldr003 · Cited by 219
Mohr, J. C., Zhang, J., Azarin, S. M., Soerens, A. G., de Pablo, J. J., Thomson, J. A., Lyons, G. E., Palecek, S. P., & Kamp, T. J. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2009.11.033 · Cited by 218
“Ultimately combining microwell technology to regulate the size of hESC colonies with controlled growth factor delivery in defined microenvironments may provide a powerful next step in the reproducible differentiation of cardiomyocytes from ESCs as well as the more recently described induced pluripotent stem cells [44–…”
MethodSelf-citationPorcine Induced Pluripotent Stem Cells Produce Chimeric Offspring
West, F. D., Terlouw, S. L., Kwon, D. J., Mumaw, J. L., Dhara, S. K., Hasneen, K., Dobrinsky, J. R., & Stice, S. L. (2010) · Stem Cells and Development · doi:10.1089/scd.2009.0458 · Cited by 224
“These findings appear to be recapitulated in human cells, as did techniques to derive human ESCs (hESCs) from early blastocyst [4], with human iPSCs (hiPSCs) displaying immunoreactivity, morphological characteristics, proliferation, epigenetic, telomerase activity, and differentiation potential almost indistinguishabl…”
InfluentialKunisada, Y., Tsubooka-Yamazoe, N., Shoji, M., & Hosoya, M. (2012) · Stem Cell Research · doi:10.1016/j.scr.2011.10.002 · Cited by 216
“002 defined transcription factors (Takahashi et al., 2007; Yu et al., 2007; Nakagawa et al., 2008).”
InfluentialThe Use of Induced Pluripotent Stem Cells in Drug Development
Inoue, H., & Yamanaka, S. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.38 · Cited by 221
Itzhaki, I., Maizels, L., Huber, I., Gepstein, A., Arbel, G., Caspi, O., Miller, L., Belhassen, B., Nof, E., Glikson, M., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.02.066 · Cited by 223
“The development of the groundbreaking human- induced luripotent stem cells (hiPSCs) technology (7,8) may proide a possible solution to the aforementioned challenges.”
BackgroundLIN28B Promotes Colon Cancer Progression and Metastasis
King, C. E., Cuatrecasas, M., Castells, A., Sepulveda, A. R., Lee, J.-S., & Rustgi, A. K. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-4637 · Cited by 224
“and KLF4 in somatic fibroblasts.”
Retinal stem cell transplantation: Balancing safety and potential
Singh, M. S., Park, S. S., Albini, T. A., Canto-Soler, M. V., Klassen, H., MacLaren, R. E., Takahashi, M., Nagiel, A., Schwartz, S. D., & Bharti, K. (2020) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2019.100779 · Cited by 225
“Modern stem cell technologies have yielded clinical grade cellular therapies that are under investigation for retinal degenerations from both human embryonic stem cells (hESCs) and induced pluripotent stem cells (iPSCs) (Drukker et al., 2006; Odorico et al., 2001; Polak and Bishop, 2006; Takahashi et al., 2007; Yu et…”
A transcription factor atlas of directed differentiation
Joung, J., Ma, S., Tay, T., Geiger-Schuller, K. R., Kirchgatterer, P. C., Verdine, V. K., Guo, B., Arias-Garcia, M. A., Allen, W. E., Singh, A., et al. (2023) · Cell · doi:10.1016/j.cell.2022.11.026 · Cited by 219
Vascular tissue engineering: Towards the next generation vascular grafts
Naito, Y., Shinoka, T., Duncan, D., Hibino, N., Solomon, D., Cleary, M., Rathore, A., Fein, C., Church, S., & Breuer, C. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.03.001 · Cited by 226
Three-dimensional biomaterials for the study of human pluripotent stem cells
Kraehenbuehl, T. P., Langer, R., & Ferreira, L. S. (2011) · Nature Methods · doi:10.1038/nmeth.1671 · Cited by 226
Signaling in adult neurogenesis
Mu, Y., Lee, S. W., & Gage, F. H. (2010) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2010.04.010 · Cited by 215
Dental Pulp Cells for Induced Pluripotent Stem Cell Banking
Tamaoki, N., Takahashi, K., Tanaka, T., Ichisaka, T., Aoki, H., Takeda-Kawaguchi, T., Iida, K., Kunisada, T., Shibata, T., Yamanaka, S., et al. (2010) · Journal of Dental Research · doi:10.1177/0022034510366846 · Cited by 221
“The same or a similar combination of factors can also generate human iPS cells (Takahashi et al., 2007; Yu et al., 2007; Aasen et al., 2008; Lowry et al., 2008; Park et al., 2008; Haase et al., 2009; Loh et al., 2009; Sun et al., 2009; Utikal et al., 2009; Yan et al., 2009).”
BackgroundSOX4: The unappreciated oncogene
Moreno, C. S. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.08.027 · Cited by 224
“SOX proteins are also key regulators of cell fate and stemness [7-9].”
BackgroundSi-Tayeb, K., Noto, F. K., Sepac, A., Sedlic, F., Bosnjak, Z. J., Lough, J. W., & Duncan, S. A. (2010) · BMC Developmental Biology · doi:10.1186/1471-213x-10-81 · Cited by 220
“Lentivirus-based reprogramming utilized the same culture conditions as described above; however, the cells were infected with concentrated replication-incompetent pseudotyped lentiviruses that express OCT4, NANOG, SOX2 and LIN28.”
BackgroundMethodInfluentialHow to make a functional β-cell
Pagliuca, F. W., & Melton, D. A. (2013) · Development · doi:10.1242/dev.093187 · Cited by 216
“In the decade following this discovery, an additional source of pluripotent stem cells was identified – induced pluripotent stem cells (iPSCs) reprogrammed from murine fibroblasts (Takahashi and Yamanaka, 2006; Wernig et al., 2007; Yu et al., 2007).”
BackgroundLin28-mediated post-transcriptional regulation of Oct4 expression in human embryonic stem cells
Qiu, C., Ma, Y., Wang, J., Peng, S., & Huang, Y. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkp1071 · Cited by 218
“The biological importance of Lin28 is further underscored by its ability to facilitate the reprogramming of human somatic cells to induced pluripotent stem (iPS) cells (7).”
BackgroundMediators of reprogramming: transcription factors and transitions through mitosis
Egli, D., Birkhoff, G., & Eggan, K. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2439 · Cited by 223
“This method has also been successfully used to reprogramme human fibroblasts to an ES-cell-like stat”
Ronaghi, M., Erceg, S., Moreno-Manzano, V., & Stojkovic, M. (2010) · Stem Cells · doi:10.1002/stem.253 · Cited by 223
Pulp and Dentin Tissue Engineering and Regeneration: Current Progress
Huang, G. T. (2009) · Regenerative Medicine · doi:10.2217/rme.09.45 · Cited by 217
“Ultimately, the paucity of stem cells may be resolved by the generation of induced pluripotent stem cells from somatic cells [85,86] such as dental stem Huang Page 7”
BackgroundEfficient Detection and Purification of Cell Populations Using Synthetic MicroRNA Switches
Miki, K., Endo, K., Takahashi, S., Funakoshi, S., Takei, I., Katayama, S., Toyoda, T., Kotaka, M., Takaki, T., Umeda, M., et al. (2015) · Cell Stem Cell · doi:10.1016/j.stem.2015.04.005 · Cited by 218
“…embryonic stem cells (hESCs) and induced pluripotent stem cells (hiPSCs), which can produce a variety of cell types and which are a potential cell source for transplantation therapy, drug efficiency evaluation, and toxicology testing (Garbern and Lee, 2013; Takahashi et al., 2007; Yu et al., 2007).”
BackgroundInduced pluripotent stem cells from highly endangered species
Friedrich Ben-Nun, I., Montague, S. C., Houck, M. L., Tran, H. T., Garitaonandia, I., Leonardo, T. R., Wang, Y.-C., Charter, S. J., Laurent, L. C., Ryder, O. A., et al. (2011) · Nature Methods · doi:10.1038/nmeth.1706 · Cited by 220
HERV-H RNA is abundant in human embryonic stem cells and a precise marker for pluripotency
Santoni, F. A., Guerra, J., & Luban, J. (2012) · Retrovirology · doi:10.1186/1742-4690-9-111 · Cited by 219
“When ectopically expressed in particular combinations, the transcription factors NANOG, OCT4, and SOX2 are capable of reprogramming mature somatic cells into pluripotent stem cells [36-39].”
BackgroundLIN28A Is a Suppressor of ER-Associated Translation in Embryonic Stem Cells
Cho, J., Chang, H., Kwon, S. C., Kim, B., Kim, Y., Choe, J., Ha, M., Kim, Y. K., & Kim, V. N. (2012) · Cell · doi:10.1016/j.cell.2012.10.019 · Cited by 220
“Lin28a is highly expressed in embryonic stem cells (ESCs) and was shown as one of the four factors that convert fibroblasts into induced pluripotent stem cells (Yu et al., 2007).”
BackgroundOmole, A. E., & Fakoya, A. O. J. (2018) · PeerJ · doi:10.7717/peerj.4370 · Cited by 204
“Nanog and Lin 28 can replace Klf4 and c-Myc respectively, and estrogen-related receptor beta (ESRRb) can replace Klf4 (Yu et al., 2007; Feng et al., 2009).”
BackgroundMethodInfluentialStem Cell Therapy in Heart Diseases – Cell Types, Mechanisms and Improvement Strategies
Müller, P., Lemcke, H., & David, R. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000492704 · Cited by 215
Teratomas from pluripotent stem cells: A clinical hurdle
Fong, C., Gauthaman, K., & Bongso, A. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22775 · Cited by 222
“…have been reported for hESCs [Reubinoff et al., 2000; Laflamme et al., 2007; Shim et al., 2007; Yang et al., 2008], hiPSCs [Takahashi et al., 2007; Yu et al., 2007; Huangfu et al., 2008], NTSCs [Byrne et al., 2007], hMSCs [Fong et al., 2007; Troyer and Weiss, 2008], and hHSCs [Zapata, 2009] and…”
BackgroundMethodInfluentialNiebruegge, S., Bauwens, C. L., Peerani, R., Thavandiran, N., Masse, S., Sevaptisidis, E., Nanthakumar, K., Woodhouse, K., Husain, M., Kumacheva, E., et al. (2009) · Biotechnology and Bioengineering · doi:10.1002/bit.22065 · Cited by 222
“In this paper we have focused on hESCs as a model system, but the described technology is broadly adaptable to other cell types, including pluripotent lines produced by iPS cells (Takahashi et al., 2007; Yu et al., 2007).”
MethodModeling Retinal Degeneration Using Patient-Specific Induced Pluripotent Stem Cells
Jin, Z.-B., Okamoto, S., Osakada, F., Homma, K., Assawachananont, J., Hirami, Y., Iwata, T., & Takahashi, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017084 · Cited by 216
“Induced pluripotent stem (iPS) cells reprogrammed from somatic cells [3,4] have enabled us to easily generate patientderived terminally differentiated cells in vitro [5–7].”
BackgroundLiu, X., Sun, H., Qi, J., Wang, L., He, S., Liu, J., Feng, C., Chen, C., Li, W., Guo, Y., et al. (2013) · Nature Cell Biology · doi:10.1038/ncb2765 · Cited by 208
Stem cells, tissue engineering and periodontal regeneration
Han, J., Menicanin, D., Gronthos, S., & Bartold, P. (2014) · Australian Dental Journal · doi:10.1111/adj.12100 · Cited by 212
Generation of integration-free neural progenitor cells from cells in human urine
Wang, L., Wang, L., Huang, W., Su, H., Xue, Y., Su, Z., Liao, B., Wang, H., Bao, X., Qin, D., et al. (2013) · Nature Methods · doi:10.1038/nmeth.2283 · Cited by 222
The pluripotency factor LIN28 marks undifferentiated spermatogonia in mouse
Zheng, K., Wu, X., Kaestner, K. H., & Wang, P. J. (2009) · BMC Developmental Biology · doi:10.1186/1471-213x-9-38 · Cited by 218
“Recently, LIN28, together with OCT4, SOX2, and NANOG, was used to reprogram human fibroblasts to pluripotent stem cells [12].”
BackgroundMethodInfluentialHuman iPSC banking: barriers and opportunities
Huang, C.-Y., Liu, C.-L., Ting, C.-Y., Chiu, Y.-T., Cheng, Y.-C., Nicholson, M. W., & Hsieh, P. C. H. (2019) · Journal of Biomedical Science · doi:10.1186/s12929-019-0578-x · Cited by 216
ApoE-Isoform-Dependent SARS-CoV-2 Neurotropism and Cellular Response
Wang, C., Zhang, M., Garcia, G., Tian, E., Cui, Q., Chen, X., Sun, G., Wang, J., Arumugaswami, V., & Shi, Y. (2021) · Cell Stem Cell · doi:10.1016/j.stem.2020.12.018 · Cited by 223
“Human-induced pluripotent stem cells (hiPSCs) have emerged as valuable in vitro platforms tomodel human brain development and diseases for which human cells and tissues are not easily accessible (Takahashi et al., 2007; Yu et al., 2007; Marchetto et al., 2011; Shi et al., 2017a; Li et al., 2018a; Li and Shi, 2020).”
Hedgehog controls neural stem cells through p53‐independent regulation of Nanog
Po, A., Ferretti, E., Miele, E., De Smaele, E., Paganelli, A., Canettieri, G., Coni, S., Di Marcotullio, L., Biffoni, M., Massimi, L., et al. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.131 · Cited by 215
“…Division of Pediatric Neurosurgery, Catholic University of Rome, Rome, Italy and 4Department of Neuroscience, Istituto Neurologico Mediterraneo Neuromed, Pozzilli, Italy Hedgehog (Hh) pathway has a pivotal function in devel- opment and tumorigenesis, processes sustained by stem cells (SCs).”
BackgroundPluripotent stem cell energy metabolism: an update
Teslaa, T., & Teitell, M. A. (2015) · The EMBO Journal · doi:10.15252/embj.201490446 · Cited by 217
“Tel: +1 310 206 6754; Fax: +1 310 267 0382; E-mail: mteitell@mednet.ucla.edu The EMBO Journal Vol 34 | No 2 | 2015 ª 2014 The Authors138 methods (Yu et al, 2007; Huangfu et al, 2008; Lowry et al, 2008; Ichida et al, 2009; Kim et al, 2009; Lin et al, 2009; Lyssiotis et al, 2009; Zhou et al, 2009a;…”
BackgroundInfluentialStemming retinal regeneration with pluripotent stem cells
Jin, Z.-B., Gao, M.-L., Deng, W.-L., Wu, K.-C., Sugita, S., Mandai, M., & Takahashi, M. (2019) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2018.11.003 · Cited by 213
“Pluripotent stem cells, including embryonic stem cells (ESCs) and iPSCs (Takahashi et al., 2007; Takahashi and Yamanaka, 2006; Thomson et al., 1998; Yu et al., 2007), are self-renewable and have the potential to differentiate into”
BackgroundSpecification and Diversification of Pericytes and Smooth Muscle Cells from Mesenchymoangioblasts
Kumar, A., D’Souza, S. S., Moskvin, O. V., Toh, H., Wang, B., Zhang, J., Swanson, S., Guo, L.-W., Thomson, J. A., & Slukvin, I. I. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.05.019 · Cited by 223
“hPSCs were maintained on irradiated mouse embryonic fibroblasts as described previously (Yu et al., 2007) and induced to differentiate in coculture with OP9 stromal cells (Vodyanik and Slukvin, 2007).”
MethodSelf-citationLu, T. M., Houghton, S., Magdeldin, T., Durán, J. G. B., Minotti, A. P., Snead, A., Sproul, A., Nguyen, D.-H. T., Xiang, J., Fine, H. A., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2016950118 · Cited by 224
“IMR90-4 hPSCs were differentiated according to the Epi-iBMEC protocol as described above.”
InfluentialNotch1 represses osteogenic pathways in aortic valve cells
Nigam, V., & Srivastava, D. (2009) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2009.08.008 · Cited by 208
“Future studies of calcification in AVICs derived from induced pluripotent stem cells [41,42] made from patients with NOTCH1mutationsmay also reveal earlymechanisms and allow formal testing of the cell fate switch hypothesis.”
Generation of mouse-induced pluripotent stem cells with plasmid vectors
Okita, K., Hong, H., Takahashi, K., & Yamanaka, S. (2010) · Nature Protocols · doi:10.1038/nprot.2009.231 · Cited by 216
Dann, C. T., Alvarado, A. L., Molyneux, L. A., Denard, B. S., Garbers, D. L., & Porteus, M. H. (2008) · Stem Cells · doi:10.1634/stemcells.2008-0134 · Cited by 214
Worringer, K. A., Rand, T. A., Hayashi, Y., Sami, S., Takahashi, K., Tanabe, K., Narita, M., Srivastava, D., & Yamanaka, S. (2014) · Cell Stem Cell · doi:10.1016/j.stem.2013.11.001 · Cited by 224
“In addition, let-7 is regulated by another heterochronic gene, LIN-28, which has also been shown to promote human reprogramming with the OS+NANOG cocktail of factors (Yu et al., 2007).”
BackgroundLou, Y.-R., Kanninen, L., Kuisma, T., Niklander, J., Noon, L. A., Burks, D., Urtti, A., & Yliperttula, M. (2014) · Stem Cells and Development · doi:10.1089/scd.2013.0314 · Cited by 211
“Human embryonic stem cells (hESCs) [1] and humaninduced pluripotent stem cells (hiPSCs) [2,3] are capable of self-renewal and differentiation into any cell in the adult human body, and, thus, they hold great promise for cell therapy, drug research, and tissue engineering.”
Wei, Z., Gao, F., Kim, S., Yang, H., Lyu, J., An, W., Wang, K., & Lu, W. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2013.05.010 · Cited by 214
“The discovery of direct reprogramming by overexpression of the transcription factors Oct4, Sox2, cMyc, and Klf4 has transformed stem cell research and inspired immense interest in the application of induced pluripotent stem cells (iPSCs) to therapeutic purposes (Takahashi and Yamanaka, 2006; Yu et al., 2007).”
BackgroundOrigin of Stem Cells in Organogenesis
Slack, J. M. W. (2008) · Science · doi:10.1126/science.1162782 · Cited by 205
Choi, K.-D., Vodyanik, M. A., Togarrati, P. P., Suknuntha, K., Kumar, A., Samarjeet, F., Probasco, M. D., Tian, S., Stewart, R., Thomson, J. A., et al. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.08.002 · Cited by 212
“All hESC/iPSC lines were maintained in an undifferentiated state on irradiated mouse embryonic fibroblasts as described previously (Yu et al., 2007).”
BackgroundSelf-citationYe, L., Chang, J. C., Lin, C., Sun, X., Yu, J., & Kan, Y. W. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904689106 · Cited by 216
Self-citationLi, L., Bennett, S. A. L., & Wang, L. (2012) · Cell Adhesion & Migration · doi:10.4161/cam.19583 · Cited by 207
“The demonstration, in 2007, that hiPSCs could be generated from human fibroblast cells has further expanded this therapeutic potential.(2,3) Like hESCs, hiPSCs are capable of differentiating into almost any tissue type in the body.”
BackgroundMethodApplication of induced pluripotent stem (iPS) cells in periodontal tissue regeneration
Duan, X., Tu, Q., Zhang, J., Ye, J., Sommer, C., Mostoslavsky, G., Kaplan, D., Yang, P., & Chen, J. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22316 · Cited by 213
“…human somatic cells with the transcription factors Oct3/4, Sox2, Klf4, and c-Myc (Takahashi and Yamanaka, 2006) or OCT3/4, SOX2, NANOG, and LIN28 (Yu et al., 2007), known to be expressed at high levels in ESCs. iPS cells are identical to natural pluripotent stem cells in many respects:…”
BackgroundCorti, S., Nizzardo, M., Simone, C., Falcone, M., Nardini, M., Ronchi, D., Donadoni, C., Salani, S., Riboldi, G., Magri, F., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004108 · Cited by 207
“Here, we derived viral vector– and transgene-free human iPSCs from SMA patients using oriP/EBNA1-based vectors (12).”
BackgroundPreclinical and Clinical Development of Noncoding RNA Therapeutics for Cardiovascular Disease
Huang, C.-K., Kafert-Kasting, S., & Thum, T. (2020) · Circulation Research · doi:10.1161/circresaha.119.315856 · Cited by 210
Choi, K.-D., Vodyanik, M. A., & Slukvin, I. I. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38591 · Cited by 212
Self-citationMathieu, J., Zhou, W., Xing, Y., Sperber, H., Ferreccio, A., Agoston, Z., Kuppusamy, K. T., Moon, R. T., & Ruohola-Baker, H. (2014) · Cell Stem Cell · doi:10.1016/j.stem.2014.02.012 · Cited by 209
“was inactivated in the stem cell stage, as has been observed previously (Takahashi et al., 2007; Xia et al., 2007; Yu et al., 2007).”
BackgroundMethodResultInfluentialTissue Engineering: Current Strategies and Future Directions
Olson, J. L., Atala, A., & Yoo, J. J. (2011) · Chonnam Medical Journal · doi:10.4068/cmj.2011.47.1.1 · Cited by 191
Human pluripotent stem cells: an emerging model in developmental biology
Zhu, Z., & Huangfu, D. (2013) · Development · doi:10.1242/dev.086165 · Cited by 202
“1B) were soon generated (Takahashi et al., 2007; Yu et al., 2007).”
BackgroundDiagnosis and treatment of type 1 diabetes at the dawn of the personalized medicine era
Akil, A. A.-S., Yassin, E., Al-Maraghi, A., Aliyev, E., Al-Malki, K., & Fakhro, K. A. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-021-02778-6 · Cited by 168
“Under the control of specific growth factors, signaling pathways and activating/inhibitory molecules [159, 160] the steps of pancreatic cell differentiation have been successfully recreated in vitro.”
BackgroundGeneration of adult human induced pluripotent stem cells using nonviral minicircle DNA vectors
Narsinh, K. H., Jia, F., Robbins, R. C., Kay, M. A., Longaker, M. T., & Wu, J. C. (2011) · Nature Protocols · doi:10.1038/nprot.2010.173 · Cited by 214
“173" language="eng" publish="issue" relation="no"> Introduction Human induced pluripotent stem cells (hiPSCs) can be derived from somatic cells through a reprogramming process driven by overexpression of a defined set of transcription factor”
Cell transplantation therapies for spinal cord injury focusing on induced pluripotent stem cells
Nakamura, M., & Okano, H. (2013) · Cell Research · doi:10.1038/cr.2012.171 · Cited by 214
Stem cell cultivation in bioreactors
Rodrigues, C. A. V., Fernandes, T. G., Diogo, M. M., da Silva, C. L., & Cabral, J. M. S. (2011) · Biotechnology Advances · doi:10.1016/j.biotechadv.2011.06.009 · Cited by 210
“Alternative methods for deriving hESCs and the advent of iPSCs (Takahashi and Yamanaka, 2006; Yu et al., 2007) may constitute relevant solutions for these problems.”
MethodGuo, L., Chen, C., Shi, M., Wang, F., Chen, X., Diao, D., Hu, M., Yu, M., Qian, L., & Guo, N. (2013) · Oncogene · doi:10.1038/onc.2012.573 · Cited by 209
Séguin, C. A., Draper, J. S., Nagy, A., & Rossant, J. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.06.018 · Cited by 212
“In the mouse, interactions between the ExEn and epiblast during gastrulation regulate events such as ectoderm cavitation (Coucouvanis and Martin, 1999), axis specification (Rossant and Tam, 2004; Tam et al., 2006), and yolk sac-mediated nutrient delivery ( Yoder et al., 1994 ).”
BackgroundRecurrent copy number variations in human induced pluripotent stem cells
Martins-Taylor, K., Nisler, B. S., Taapken, S. M., Compton, T., Crandall, L., Montgomery, K. D., Lalande, M., & Xu, R.-H. (2011) · Nature Biotechnology · doi:10.1038/nbt.1890 · Cited by 213
Dynamic single-cell imaging of direct reprogramming reveals an early specifying event
Smith, Z. D., Nachman, I., Regev, A., & Meissner, A. (2010) · Nature Biotechnology · doi:10.1038/nbt.1632 · Cited by 203
The bioethics of stem cell research and therapy
Hyun, I. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40435 · Cited by 199
Molecular and Cellular Regulation of Skeletal Myogenesis
Comai, G., & Tajbakhsh, S. (2014) · Current Topics in Developmental Biology · doi:10.1016/b978-0-12-405943-6.00001-4 · Cited by 208
Regulation of embryonic stem cell self-renewal and pluripotency by leukaemia inhibitory factor
Hirai, H., Karian, P., & Kikyo, N. (2011) · Biochemical Journal · doi:10.1042/bj20102152 · Cited by 194
myc maintains embryonic stem cell pluripotency and self-renewal
Varlakhanova, N. V., Cotterman, R. F., deVries, W. N., Morgan, J., Donahue, L. R., Murray, S., Knowles, B. B., & Knoepfler, P. S. (2010) · Differentiation · doi:10.1016/j.diff.2010.05.001 · Cited by 205
“iPS cells have subsequently been produced by many other groups (Yamanaka, 2009) and in the course of these studies, although iPS cell production without ectopic c-myc has been reported (Nakagawa et al., 2008; Yu et al., 2007), efficiency was dramatically reduced highlighting an important role for myc in establishing p…”
BackgroundLai, Y., Sun, Y., Skinner, C. M., Son, E. L., Lu, Z., Tuan, R. S., Jilka, R. L., Ling, J., & Chen, X.-D. (2010) · Stem Cells and Development · doi:10.1089/scd.2009.0217 · Cited by 208
Yang, D., Scavuzzo, M. A., Chmielowiec, J., Sharp, R., Bajic, A., & Borowiak, M. (2016) · Scientific Reports · doi:10.1038/srep21264 · Cited by 200
Ho, P. W.-L., Leung, C.-T., Liu, H., Pang, S. Y.-Y., Lam, C. S.-C., Xian, J., Li, L., Kung, M. H.-W., Ramsden, D. B., & Ho, S.-L. (2020) · Autophagy · doi:10.1080/15548627.2019.1603545 · Cited by 207
“This cDNA insert of PAmCherry1 was then sub-cloned into a lentiviral backbone plasmid pSIN4-EF2IRES-Pur derived from a gift from James Thomson (AddgeneTM plasmid, 16580) [81] to construct pSIN4-PAmCherry plasmid.”
MethodAnaniev, G., Williams, E. C., Li, H., & Chang, Q. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025255 · Cited by 203
“The Thomson group independently demonstrated that iPSCs could be generated from human adult fibroblasts [20] by lentivirus mediated expression of overlapping but different combination of stem cell factors: OCT4, SOX2, NANOG, and LIN28.”
BackgroundMethodInfluentialPhillips, M. J., Wallace, K. A., Dickerson, S. J., Miller, M. J., Verhoeven, A. D., Martin, J. M., Wright, L. S., Shen, W., Capowski, E. E., Percin, E. F., et al. (2012) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.11-9313 · Cited by 201
“RT-PCR to analyze transgene and endogenous mRNA expression in iPSCs was carried out using primers previously described.(20,21) All other primers were designed using Primer3 software and are listed in Supplemental Table 2.”
MethodChen, Y. S., Pelekanos, R. A., Ellis, R. L., Horne, R., Wolvetang, E. J., & Fisk, N. M. (2012) · Stem Cells Translational Medicine · doi:10.5966/sctm.2011-0022 · Cited by 216
Induced pluripotent stem cell derived cardiomyocytes as models for cardiac arrhythmias
Hoekstra, M., Mummery, C. L., Wilde, A. A. M., Bezzina, C. R., & Verkerk, A. O. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00346 · Cited by 204
Gaudin, R., Knipfer, C., Henningsen, A., Smeets, R., Heiland, M., & Hadlock, T. (2016) · BioMed Research International · doi:10.1155/2016/3856262 · Cited by 207
“, skin fibroblasts) into induced pluripotent stem cells (iPSCs) [163].”
BackgroundWang, S., Xia, P., Ye, B., Huang, G., Liu, J., & Fan, Z. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2013.10.005 · Cited by 209
“Originally, four core transcriptional factors (Oct4, Sox2, Klf4 and c-Myc, termed OSKM) were identified as being able to convert differentiated fibroblasts into induced pluripotent stem cells (iPSCs) (Takahashi et al., 2007; Takahashi and Yamanaka, 2006; Yu et al., 2007).”
BackgroundSpecification of Midbrain Dopamine Neurons from Primate Pluripotent Stem Cells
Xi, J., Liu, Y., Liu, H., Chen, H., Emborg, M. E., & Zhang, S. (2012) · STEM CELLS · doi:10.1002/stem.1152 · Cited by 205
Generation of Functional Ventricular Heart Muscle from Mouse Ventricular Progenitor Cells
Domian, I. J., Chiravuri, M., van der Meer, P., Feinberg, A. W., Shi, X., Shao, Y., Wu, S. M., Parker, K. K., & Chien, K. R. (2009) · Science · doi:10.1126/science.1177350 · Cited by 209
Metadata
- Authors
- Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., Slukvin, I. I., & Thomson, J. A.
- Affiliations
- WiCell (US)
- Genome Center of Wisconsin, Madison, WI 53706–1580, USA.
- Venue
- Science
- Published
- 2007-12-21
- Volume
- 318
- Issue
- 5858
- Pages
- 1917-1920
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2142046859
- Cited by
- 10,310
- References
- 14
- Citations by year
- 2026: 167 · 2025: 219 · 2024: 285 · 2023: 322 · 2022: 332 · 2021: 506 · 2020: 441 · 2019: 443 · 2018: 452 · 2017: 515 · 2016: 580 · 2015: 652 · 2014: 692 · 2013: 816 · 2012: 940
- FWCI
- 271.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of General Medical Sciences (P20GM069981)
- National Center for Research Resources (P51RR000167)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Keywords
- induced pluripotent stem cells, somatic cell nuclear transfer, reprogramming factors, Oct4, SOX2, Nanog, Lin28, pluripotency, telomerase activity, germ layer differentiation, karyotype, disease models, drug development, transplantation medicine
- MeSH terms
- Nanog Homeobox Protein, Animals, Cell Differentiation, Cell Line, DNA-Binding Proteins, Fetus, Fibroblasts, Humans, Infant, Newborn, Karyotyping, Teratoma, Transcription Factors, Transduction, Genetic, Mice, SCID, RNA-Binding Proteins, Homeodomain Proteins, Transgenes, Oligonucleotide Array Sequence Analysis, HMGB Proteins, Stem Cell Transplantation, Pluripotent Stem Cells, Cell Shape, Cell Proliferation, Octamer Transcription Factor-3, Mice, Embryonic Stem Cells, SOXB1 Transcription Factors, Cellular Reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.